ORTEXORTEX News
Tracking INTC? Get live short interest, options flow, and signals on ORTEX.Sign up free →
IN
Trader NoteINTC

Intel Q3 Eve: Shorts at Cycle High, Street Ambivalent

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 21 Oct 2026, 18:31

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Intel goes into Thursday's Q3 print with short sellers at their most committed level in over a year, the stock down 11% on the week, and a Street consensus that has moved from hostility to reluctant neutrality rather than conviction.

Short interest has climbed to 3.55% of free float, with 169.5 million shares borrowed as of Tuesday. That is up 10% over the past month, the trend accelerating through September and now sitting at the highest level ORTEX has recorded for this cycle. The week-on-week increase of 1.4% is modest in isolation, but it extends a run that began in mid-September without any meaningful reversal. One notable detail: despite the build in borrowed shares, the lending market remains completely unstressed. Borrow costs have actually fallen sharply, dropping 53% on the week to just 0.25%. Availability is essentially uncapped, with over 5.2 billion shares still available to lend. There is no squeeze pressure in the borrow pool whatsoever. Short sellers have been adding positions at low cost and with no friction, which makes this a deliberate directional bet rather than a technical overhang.

The analyst picture is one of collective caution arriving late. JP Morgan's Harlan Sur ended a multi-year Underweight stance on Monday, upgrading to Neutral while keeping his target at $85, below where the stock now trades. That combination, a formal capitulation paired with a target that still implies downside, says more about how far the stock has fallen than it does about restored confidence. Susquehanna cut its target from $115 to $105 this morning, maintaining Neutral. TD Cowen similarly trimmed from $115 to $95 earlier in the week, also keeping a Hold. The mean target across the Street sits at $117, implying upside from the current $91.69 close, but most of those targets were set before October's correction. No analyst has upgraded to Buy into the print. The EPS momentum factor scores are among the strongest in the dataset, ranking in the 89th percentile on a 90-day basis, and the analyst recommendation differential ranks in the 91st percentile, reflecting how far the consensus has moved from its prior bearishness. The valuation picture is less flattering: the price-to-book multiple has compressed 26% over 30 days to 3.87, and the EV/EBITDA of 17.6 has also drifted lower, suggesting the market is re-marking the growth premium downward even as the underlying earnings trajectory has improved.

The one genuinely bullish insider signal on record remains CEO Lip Bu Tan's open-market purchase of 105,263 shares at $95 on August 11, a $10 million discretionary buy with no 10b5-1 plan attached. That purchase is now underwater by roughly 3% at current prices. No insider has bought since. Net insider activity over the 90 days to that date was a modest positive at around $7.5 million, almost entirely attributable to that single CEO transaction. The CEO's willingness to buy at $95 before the October selloff is the floor reference the market will be working against when the Q3 numbers land.

The historical earnings reaction data is unambiguous in one direction: the last four prints have all produced negative next-day moves. The most recent, reported in late July, sent the stock down 8.5% on the day and 10% over the following week. The print before that fell 10% in a single session. The five-day reaction to each of the last three quarters has ranged from minus 10% to minus 11%. Options positioning is only marginally more defensive than its recent average, with the put/call ratio at 0.873 against a 20-day mean of 0.858, a z-score of just 0.63. That is a long way from the kind of extreme hedging that preceded some of the larger single-day moves in the data. Either the options market has already priced in a poor reaction through the stock's 11% pre-earnings decline, or positioning has not yet fully caught up with the risk embedded in the history.

The peer group offers little comfort as a backdrop. AMD lost 11.7% on the week. LRCX fell 12.5%. FORM dropped 15.9% and MXL gave back 17.1%. The broader semiconductor complex is under pressure into earnings season, which means Thursday's Intel print will be read as a sector data point as much as a company-specific one. What the Q3 report needs to address is whether Q2's 25% revenue growth and 59% Data Center gain were a turning point or a high-water mark, and whether the foundry margin trajectory is running ahead of or behind the targets management put on the table earlier this year. The short position, the earnings history, and the analyst ambivalence will all be measured against those two numbers.

Stocks in this article

See the live data behind this article on ORTEX.

Open INTC on ORTEX →

How this article was generated

Generated
21 Oct 2026, 18:34
Data as of
21 Oct 2026, 18:31
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.